Immunomodulator compounds
US10639284B2 · kind B2 · utility
13Cited by
0References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2017 |
| Grant date | May 5, 2020 |
| Priority date | — |
| Expiry date | Jun 26, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are provided that are useful as immunomodulators. The compounds have the following Formula (II): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, R2a, R2b, R2c, R3, R4, R5, R6a, R6b, m and n are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.